Sir Pascal Soriot (pictured) is reportedly weighing the move for the drugs giant amid growing frustration with the UK’s rules on approving new medicines.Read More
You might also be interested in reading Banks’ Capital Rules When Holding Crypto Need to Be Reworked, Says Basel Chair: FT.